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METHODOLOGY ARTICLE

Open Access

Estimation of CpG coverage in whole methylome
next-generation sequencing studies
Edwin JCG van den Oord*, Jozsef Bukszar, Gábor Rudolf, Srilaxmi Nerella, Joseph L McClay, Lin Y Xie
and Karolina A Aberg

Abstract
Background: Methylation studies are a promising complement to genetic studies of DNA sequence. However,
detailed prior biological knowledge is typically lacking, so methylome-wide association studies (MWAS) will be
critical to detect disease relevant sites. A cost-effective approach involves the next-generation sequencing (NGS) of
single-end libraries created from samples that are enriched for methylated DNA fragments. A limitation of singleend libraries is that the fragment size distribution is not observed. This hampers several aspects of the data analysis
such as the calculation of enrichment measures that are based on the number of fragments covering the CpGs.
Results: We developed a non-parametric method that uses isolated CpGs to estimate sample-specific fragment size
distributions from the empirical sequencing data. Through simulations we show that our method is highly accurate.
While the traditional (extended) read count methods resulted in severely biased coverage estimates and introduces
artificial inter-individual differences, through the use of the estimated fragment size distributions we could remove
these biases almost entirely. Furthermore, we found correlations of 0.999 between coverage estimates obtained
using fragment size distributions that were estimated with our method versus those that were “observed” in paired-end
sequencing data.
Conclusions: We propose a non-parametric method for estimating fragment size distributions that is highly precise and
can improve the analysis of cost-effective MWAS studies that sequence single-end libraries created from samples that are
enriched for methylated DNA fragments.
Keywords: Methylation, Next-generation sequencing, MBD/MeDIP, Association studies

Background
Methylation studies are a promising complement to genetic studies of variation in DNA sequence and structure.
Most intensively studied is the methylation of DNA
cytosine residues at the carbon 5 position (5meC).
Methylation is typically associated with transcriptional
repression [1,2]. This direct link to gene expression
means that methylation studies can potentially capture
more individual variation in disease susceptibility.
Methylation studies can also shed a unique light on
disease mechanisms and clinical phenomena [2,3] such
as sex differences [4,5], genotype environment interactions
[3,6], and age-related patterns associated with the disease
course [7]. Finally, methylation sites are appealing from a
* Correspondence: ejvandenoord@vcu.edu
Center for Biomarker Research and Personalized Medicine, School of
Pharmacy, Virginia Commonwealth University, 1112 East Clay Street, P.O. Box
980533, Richmond, VA 23298, USA

translational perspective because they are modifiable
by pharmacological interventions [8] and are easy to
measure using cost-effective assays in readily available
biosamples [9].
For most common, complex diseases, detailed prior
biological knowledge is typically lacking. Therefore,
genome-wide approaches that proved fruitful in the
context of sequence variants [10] will also be critical to
detect disease relevant methylation sites [11-13]. Nextgeneration sequencing (NGS) is an appealing technology
for such methylome-wide association studies (MWAS).
Compared to arrays, NGS provides better coverage of all
possible methylation sites in the human genome [14].
Furthermore, the relatively low amounts of starting
material will reduce errors and bias caused by sample
preparation and amplification. Finally, the availability of
fast semi-automated sample preparation, the increase in
the amount of data generated per run, and the decrease
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in reagent costs have already made NGS a cost-effective option for a comprehensive interrogation of the methylome.
The most comprehensive method for ascertaining
methylation (5meC) status at each nucleotide position is
bisulfite sequencing [15], where unmethylated cytosines
in genomic DNA are converted to uracil and then
converted to thymine in post-bisulfite PCR [16]. The
single base resolution is attractive because it allows
precise mapping of disease relevant sites [14]. However,
due to the combination of high costs of sequencing
entire genomes and the large numbers of samples needed
to provide adequate statistical power, whole-genome
bisulfite sequencing is not currently economically feasible
as a screening tool for disease association studies [11]. A
commonly used cost-effective alternative aims to sequence
only the methylated part of the genome. Here, DNA is
first fragmented and the methylated fragments are bound
to antibodies [17] or other proteins [18] with high affinity
for methylated DNA. The unmethylated genomic fraction
is washed away, and the methylation-enriched portion of
the sample is then collected and sequenced [18-21].
Knowledge of the fragment size distributions in
enrichment-based MWAS is important for several
aspects of the data analysis. A clear example involves the
calculation of enrichment measures. DNA methylation is
most often, although not exclusively, found in the
sequence context CpG. Certain enrichment protocols
(e.g. MBD-based capture that uses the methyl binding
domain of methyl binding proteins [18]), can even only
detect CpG methylation. Given that we know exactly
where the CpGs are located, there is no need to search
for enrichment peaks using methods commonly used in
ChIP-seq experiments [22-26]. Although there are other
ways to quantify enrichment [27], a commonly used
approach is to count the number of fragments covering
each CpG. If the fragment sizes are unknown, the
number of reads covering the CpG is typically counted
instead [21], where read length is sometimes extended
to the expected fragment length. However, this is a
rough approximation. First, due to the stochastic nature
of DNA fragmentation, one cannot assume an equal size
for all fragments. Second, the expected fragment size
may be mis-specified if the sequenced fragment pool
differs from the one obtained after fragmentation. This
could arise, for example, if smaller fragments are more
likely to be pulled down in the enrichment step. Third,
there will be variation in the fragment size distribution
across samples despite standardized lab protocols. The
possible implication of using the read count approximation
is therefore that coverage estimates may become biased
and imprecise.
A second example illustrating the importance of the
fragment size distribution is that failure to account for
differences in fragment size distributions between
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samples may create artificial inter-individual differences
in coverage estimates. To illustrate this, assume that in
sample A all DNA fragments are exactly 50 bases in
length and that we sequence at 50 bp read length. When
using a read count to calculate coverage for the CpG
that caused the enrichment, all reads will contribute to
this count because the start positions of all aligned reads
will be within 50 bp of that methylated CpG. Now
assume a second sample B that has identical methylation
levels at the target CpG. However, for this sample all
fragments are 200 bp long, but we still sequence only
50 bp of each fragment. As only a proportion of the
reads would now start within 50 bases of the CpG, the read
count will be less than for sample A and underestimate the
number of fragments covering the target CpG.
Rather than using an estimation procedure, by sequencing paired-end libraries we can obtain the fragment size
distribution by subtracting the start positions of successfully
aligned read pairs. However, paired-end libraries have only
recently become available, so legacy data is typically singleend and not all sequencing platforms currently support
paired-end libraries. Second, the use of paired-end libraries
is more expensive and almost doubles the sequencing run
time. These disadvantages may be justified in studies that
require single base resolution, such as calling DNA
sequence variants or estimating the percentage of methylation at specific bases after bisulfite conversion. In these
scenarios, the number of reads covering each base is a
critical determinant of data quality. However, for the
enrichment-based methylation studies considered in this
paper, it is the number of sequenced fragments that
determine data quality. As the use of paired-end libraries
does not increase the number of fragments, one could
argue that it is better to spend the additional resources on
sequencing more fragments using single-end libraries.
The goal of our investigation is to develop a method
that uses single-end sequencing data to estimate
fragment size distributions. Due to the nature of the
sequencing technology as well as specific lab procedures
to optimize the assays (e.g. size selection on fragments
prior to sequencing), it is difficult to make strong parametric assumptions about this distribution. Therefore,
we propose a non-parametric method. To validate our
method, we performed simulation studies and made
comparisons with NGS studies of paired-end libraries,
which provide a benchmark by allowing an empirical
determination of the fragment size distribution.

Methods
A detailed exposition of the proposed method to estimate CpG coverage can be found in the supplemental
material and we confine ourselves here to a summary. In
contrast to for example Chip-seq data, in methylation
studies there are often many sites that are located close
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to each and all can affect the enrichment. This
complicates the estimation of the fragment size distribution. For example, using all reads in the neighborhood of
a CpG that has other CpGs nearby will give imprecise
estimates of the fragment size distribution because part
of the enrichment at that locus will be the result of the
nearby CpGs. To address this problem, our method uses
only isolated CpGs. An isolated CpG is defined as a site
C for which the interval [C-d,C + d] contains no other
CpGs but C and where d is larger than the longest
possible fragment size. For these isolated CpGs it is
reasonable to assume that, given the fragment size X = x,
the possible nucleotide positions R where the reads
can start is independent and uniform distributed (see
Additional file 1: Figure S3 and Results section for empirical support of this assumption).
From this assumption it follows that the probability
mass function of the possible read start position R
equals:
PrðR ¼ r Þ ¼

s
X
PrðxÞ
x
x¼rþ1

ð1Þ

where Pr(x) denotes the probability that fragments have
size x, and s is the size of the longest fragment. The
summation over fragments starts at r + 1, because
fragments can only have reads with a start position r if
x > r. We obtain the probability mass fragment size function by solving Pr(x) from (1):
PrðX ¼ r Þ ¼ ðPrðR ¼ r  1Þ  PrðR ¼ r ÞÞ  r

ð2Þ

Because the enrichment is imperfect, not all sequenced
fragments will contain methylated CpGs. Under the
assumption that the start positions of such “noise” reads
are uniformly distributed in the [C-d,C + d] interval, they
will not bias estimates because Pr(x) in (2) is calculated
from the difference between the numbers of reads
starting at adjacent bases.
We need to know for each read the probability that
the fragment it is tagging covers that CpG. This coverage
function is equal to the complement of cumulative fragment size function 1-(F(x)) or
PrðX > r Þ ¼

s
X

PrðxÞ

ð3Þ

x¼rþ1

For example, if the read length is 50, Pr(X > r) = 1.0 for
reads starting within 50 bp of the CpG but Pr(X > r) < 1.0
for reads starting further away as part of the tagged
fragments will be too short to cover the CpG. Once we
determined for every read the probability that the
fragments they are tagging cover the CpG, these probabilities can be summed over all reads to obtain a coverage estimate for the CpG.

An expected contribution of a randomly chosen read
to the coverage, E(cov), can be calculated by combining
(1) that gives the distribution of read start positions with
(3) that specifies how reads starting at these locations
contribute to coverage:
E ð covÞ ¼

s1
X

PrðR ¼ r ÞPrðX > r Þ

ð4Þ

x¼0

Equation (4) shows that E(cov) depends on the
fragment sizes. The implication is that coverage
estimates will differ across samples if the fragment sizes
differ across these samples. However, because the
fragment size distribution is determined by the lab
protocol and is not directly related to the amount of
methylation, this difference represents an artifact. To
avoid such differences it may be necessary to standardize
the coverage estimates using this expected contribution.
We calculated the required coverage standardization
factor for each sample as the mean of the expected read
contributions across all samples in the study divided by
E(cov) in (4) for that specific sample.
Estimation procedure

We apply the following stepwise procedure to estimate
the coverage function in (3).
1) Select the isolated CpG sites for the chosen interval
[C-d,C + d] and count all the read start positions in
the vicinity of these isolated sites. For reads aligning
to the forward strand this involves all reads starting
in the C-d interval that is upstream of the CpG, and
for reads on the reverse strand all reads starting in
the (C + 1) + d interval that is downstream of the
CpG. A value for d can be obtained from a visual
inspection of an initial plot of the read start counts.
For example, the dots in Figure 1 show an example
where these counts decrease until position 240 after
which they start to fluctuate around the “noise” level.
This pattern suggests that very few fragments are
longer than 240 and for d we could therefore choose
a value between 250–300 bp.
2) As the read start counts will show sampling
fluctuations, we “smooth” the data prior to
calculating Pr(x) with formula (2). Our first method
involved the Nadaraya-Watson estimator [28,29].
This smoother takes for each position the m nearest
neighbors and estimates the number of read starts by
averaging the values across this window using a
kernel as a weighting function. As it essentially uses
the mean, this kernel-based smoother assumes that
the underlying function is locally constant. To
provide an alternative we also used a cubic spline
method that fits a more flexible local regression
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Figure 1 Counts of read start positions and fitted smoothing
functions. Points are actual counts, thick line is the kernel-based
smoother, and the thin line is the qubic spline smoother.
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We could map 87% of the reads. Using d = 350 bp, the total
number of isolated CpGs was 287,493 which corresponds
to 1.4% of all CpGs in the C57BL/6 genome (build 9/
NCBI37). In terms of uniquely mapped reads, an average of
184,853 reads per sample mapped to isolated CpGs.
Fifty-two percent of the mapped reads (or 45% of total
reads) satisfied our criteria for high quality read pairs
meaning that they aligned uniquely with the right orientation and acceptable fragment size. We obtained the
fragment size distributions from the paired-end data by
subtracting the start positions of the successfully aligned
read pairs. Although these fragment size distributions may
not be perfect (e.g. only a proportion of the read pairs are
used and the fragments tagged by these high quality pairs
may not be completely representative of all sequenced
fragments), they should provide a good opportunity to
validate findings as the distributions are “observed” and
do not require estimation.

Results
Simulation studies

model instead. We illustrate results obtained with
the two methods in Figure 1.
3) Step 2 results in a set of estimates of Pr(x) that are
used in step 3 to calculate the coverage function (3).
The true underlying coverage function (3) is
monotone descending but in practice this may not
hold due to sampling fluctuations. To ensure
monotonicity, as a final smoothing step we used the
procedure proposed by Dette et al. [30,31].
To obtain the coverage functions and standardization
factors we wrote an R function that also summarizes
and plots the (smoothed) data. For the kernel-based
smoother we used the R function ksmooth. For the
cubic spline we used smooth.spline, the design of which
parallels the smooth.spline function of Chambers and
Hastie [32]. The function monoProc was used in the
final step to obtain monotone descending coverage
functions. We also created a program to create the input
data, which is a table with the counts of the read starts
around isolated CpGs. Prior to calculating this table, the
program allows user specified quality control (QC) of the
reads. Because of the size of the data files, this program
was coded in C++. The source code, Windows and Linux
executables, and documentation are freely available from
http://www.people.vcu.edu/~ejvandenoord/.

Figure 2 depicts three fragment size probability mass
functions, selected from our sequencing study in eight
mice, which were calculated from the paired-end data as
indicated above. The figure clearly shows non-normal
distributions supporting our argument that non-parametric
methods are needed to accurately characterize them.
Part of the non-normality can be explained by size selection, a standard step in NGS library construction that aims
at eliminating short and long fragments. The sharp decline
in the number of fragments at around 230–240 bp seen
for the kurtotic distribution, for example, is likely the result of successfully eliminating long fragments. Figure 2

Empirical data used to test method

To validate our method we sequenced 50 bp + 35 bp
paired-end libraries in 8 inbred adult C57BL/6 male mice
(see supplemental material for details on the laboratory
methods, quality control, and data processing). The
number of reads per sample was on average 53.6 million.

Figure 2 Probability mass fragment size distributions. The three
examples were obtained using successfully aligned read pairs our
sequencing study in mice.
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also shows that despite the use of size selection and a
standard protocol to fragment the DNA, considerable variation exists in the individual fragment size distributions.
This suggests that fragment size estimation methods
assuming the same distributional form for all samples are
at risk for producing biased results.
To test our estimation procedure through simulations,
we generated 10,000 random samples based on each of
the three distributions in Figure 2. The number of reads
with start positions close to isolated CpGs equaled
10,000, 25,000, 50,000, 75,000, or 100,000. The condition
that assumes 100,000 reads is comparable to what we
observe in our empirical data. The other conditions
enable us to get a sense of the robustness of our method
in case fewer reads would be available. To assess the
precision of our estimator, we first calculated the mean
difference and absolute mean difference between the
estimated coverage function and the real coverage
function used to simulate the data, and then averaged
these differences across all possible read start positions.
When subsequently averaged across the 10,000 simulated
samples, the mean difference provides information about
whether there are systematic differences (=bias) between
estimated and true coverage functions. To obtain a measure
of the variability of the estimated coverage functions, we
also calculated the standard deviation of the mean difference in the 10,000 simulations. Finally, the mean of the
absolute differences across the 10,000 simulations provides
an overall measure of precision that incorporates both
systematic differences and the variability of the estimates.
All three statistics in Table 1 show that precision
increased with sample size. The mean was very close to
zero, suggesting that the estimates were unbiased. The
small standard deviation and mean absolute difference
suggested that our method was precise. In addition to
sample size, the fragment size distribution type affected the
precision of the estimates (see Additional file 1: Figure S1).
The least precise estimates were obtained for the kurtotic
distribution and the most precise estimates for the distribution that was positively skewed. In Table 1 results for the
kernel-based method are shown but those obtained using
cubic splines were almost identical.
Figure 3 displays estimated coverage functions for the
condition with 50,000 reads. The Additional file 1:
Table 1 Summary of simulation results comparing
estimated and true coverage curves with different
numbers of reads
# reads

Figure 3 Selection of estimated coverage functions for
simulation conditions with 50,000 reads. The three fragment size
distributions depicted in Figure 2 were used to simulate the data,
where the coverage function implied by these three distributions is
represented by the solid lines. The dashed lines indicate the mean
of the estimated across all 10,000 simulations. The dotted line is an
example of an estimated coverage function that has mean error
identical to the 99th percentile of the 10,000 estimates.

Figure S2 a-d shows similar plots for the conditions with
10,000, 25,000, 75,000, and 100,000 reads. Results are
shown for the three fragment size distributions depicted
in Figure 2 that were used to simulate the data, where
the coverage function implied by these three distributions
is depicted as well. Figure 3 shows that the mean of the
estimated coverage functions across all 10,000 simulations
almost perfectly traced the coverage function used to
generate the data. This suggests that our estimation
procedure is unbiased. The figure also displays an example
of a coverage function that has a mean absolute difference
identical to the 99th percentile of all 10,000 estimates.
The fact that this curve is also very close to the true coverage function suggests that the variability is modest and
that our method almost always yields a good approximation to the actual function. Further analyses showed that
our method is robust, because even with as few as 10,000
reads (Additional file 1: Figure S2a) with start positions
around isolated CpGs, the estimation is precise.
Estimating coverage functions with empirical data

10,000

25,000

50,000

75,000

100,000

Mean

−0.00017

−0.00018

−0.00024

−0.00034

−0.00060

Standard
deviation

0.00693

0.00444

0.00323

0.00263

0.00212

Absolute
difference

0.01225

0.00827

0.00613

0.00512

0.00461

Additional file 1: Figure S3 shows the plots with read
start position distributions for each of the 8 samples.
These distributions show systematic outliers at the very
beginning of the read (positions 0–4). However, after
these initial positions, the frequencies of the read start
positions do not show a systematic trend until the read
length is reached. The decay after that point is expected
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and caused by parts of fragments becoming too short to
cover the CpG (see Formula 1), which essentially forms
the basis of our estimator. In other data, we have sometimes observed a decay that starts before the read length
is reached. However, this was the result of some
fragments being shorter than the read length. Such
fragments can occur when the instrument initially
sequences part of the adaptor. These reads are then
“trimmed” during alignment. Thus, when the methylated
CpG is at the very beginning of the read, the assumption
of uniform read start distribution does not hold.
However, as our estimator only uses the data starting
from approximately the minimum read length, these
outliers do not affect the estimation. The absence of a
systematic trend until the minimum fragment length is
reached suggests that the assumption of a uniform
distribution for position-level read counts is reasonable
for the range from which the data are used.
Before estimating the coverage function using the
empirical sequencing data, we first eliminated one read
from each pair as to create single-end read input data.
Empirical data will comprise multi- and duplicate-reads.
Many reads map to multiple locations of the genome.
Often a single alignment can be selected because it is
clearly better than the others. In the case of multi-reads,
multiple alignments are about equally good. Selecting
only the best alignment for each multi-reads read carries
along the danger of alignment errors (e.g. alignments to
regions with SNPs are less likely to be best alignments
because SNPs cause mismatches). On the other hand, excluding all multireads may affect accuracy in a negative way
[33]. Duplicate-reads are reads that start at the same nucleotide positions. When sequencing a whole genome
duplicate-reads often arise from template preparation or
amplification artifacts. In our context of sequencing an
enriched genomic fraction, duplicate-reads are increasingly
likely to occur by chance because reads are expected to
align to a much smaller fraction of the genome.
We examined empirically whether it would be better
to allow for a limited set of high quality multi- and duplicate reads or exclude all such reads. To select high
quality multi-reads, any read that mapped to more than
10 loci was excluded from further consideration. From the
remaining multi-reads, we selected those that aligned
almost equally well to only a few loci. Specifically, we
selected the multi-reads that had fewer than five alignments
with alignment scores (read length ‒ 3 × the number of
mismatches) within five points of the best score. To avoid
disproportionate representation, multi-reads were weighted
in proportion to the number of alignments in the coverage
calculations. In all instances where >3 (duplicate) reads
started at the same position, we reset the read count to 1
for the coverage calculations assuming that these reads all
tagged a single fragment. If 2 or 3 reads started at the same
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Table 2 Precision coverage function estimated after
different QC procedures for duplicate- and multi-reads
multi

multi

no multi

no multi

duplicate no duplicate duplicate no duplicate
# reads/sample

297,405

253,601

217,745

184,853

Mean

−0.0078

−0.0079

−0.0112

−0.0132

Standard deviation

0.0214

0.0217

0.0222

0.0243

Absolute difference

0.0178

0.0181

0.0194

0.0207

Note: # reads/sample is the number of reads around isolated CpGs used as
input for our estimation method.

position, we looked for other reads in neighborhood
±25 bp. If other reads mapped to this area, we retained the
read count of 2 or 3 in the coverage calculations, assuming
that the duplicate reads occurred by chance due to enrichment of fragments caused by methylated CpG in the
region. If no other reads were found, we assumed that the
duplicate reads were artifacts and reset the read count to 1
for the coverage calculations.
In Table 2 we report the mean, standard deviation,
and absolute mean difference between the estimated
coverage function (see text Table 1 for discussion of
these indices) and the coverage function as implied by
the paired-end fragment size distributions of the 8
samples. The most precise results were obtained by
including high-quality multi- and duplicate-reads. Here,
the mean was closest to zero indicating almost unbiased
estimates, the standard deviation was smallest implying
that the estimates were less variable, and the mean of
the absolute difference that is a function of both a possible
bias plus the variability in the estimates was also smallest.
Comparisons suggest multi-reads are more critical for
precision than duplicate-reads. As shown by the first row of
Table 2, the proportion of high quality multi- (about 20%)
and duplicate reads (about 15%) can be substantial. This
larger number of observations when multi- and duplicatereads are used in for the estimation may explain the higher
precision of the estimates.
Figure 4 displays the coverage functions obtained
using the successfully aligned paired-end read pairs from
the three samples from Figure 2 as well as the estimated
functions. The good correspondence suggested that the
estimation method worked well with empirical data.
However, considering the relatively large number of
reads, the correspondence is not as good as observed
with the simulated data. This may be because of assay
related factors that influence empirical read start data
and/or the possibility that paired-end data may provide
only an approximation of the true coverage function. In
Figure 5 we show the mean of the estimated coverage
functions across all eight mouse samples. This mean
closely tracks the corresponding mean in the paired-end
data suggesting that most of the deviations seen for the
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Table 3 Comparison of coverage estimates obtained
using different methods
Mean

SD

Ratio

Paired-end

6.168

3.282

100.0%

Correlation
1.000

Read count (50 bp)

1.824

1.357

29.6%

0.608

Read count extended (150 bp)

5.385

3.036

87.3%

0.934

Individual kernel function

6.207

3.287

100.6%

0.999

Mean paired-end function

6.202

3.331

100.6%

0.986

Mean kernel function

6.251

3.356

101.4%

0.986

Note: Ratio is mean divided by mean of paired-end data and Correlation is the
correlation between coverage calculations with the method listed in the row
versus those obtained from the paired-end data.

Figure 4 Coverage functions estimated from the empirical
data. The solid lines represent three distributions calculated using
successfully aligned paired-end reads. The dashed lines are the
estimates that allow for high quality multi- and duplicate reads.

individual estimates in Figure 4 are not systematic. As
the use of the mean distribution may be an alternative in
situations where the individual distributions are
considered unstable, we will study this mean function in
our next section on coverage estimation as well.
Coverage estimation

In Table 3 we report results from various coverage
calculations performed on the mouse data. Coverage
was calculated for all 20.4 million CpGs of the 19

Figure 5 Mean coverage function for all 8 samples. The solid
lines represent three distributions calculated using successfully
aligned paired-end reads. The dashed lines is an estimate based on
the mean across all 8 samples.

autosomal mouse chromosomes. The first row shows the
coverage calculations using the fragment size distributions
as “observed” in paired-end read data. These coverage
estimates were used as the benchmark. Next, we present a
“traditional” coverage calculation where we counted the
number of sequence reads covering the CpGs. Results
show that this method severely underestimates the
coverage. More precisely, the “ratio” column shows that
the mean coverage is merely 29.2 percent of that obtained
after analyzing the paired-end data. Furthermore, when
we correlated these coverage estimates with those
obtained from the paired-end data, we only obtained a
very modest correlation of 0.606. The DNA samples were
fragmented by ultrasonication (Covaris, Woburn, MA) to
a target median size of 150 bp. For the coverage
calculations in the next row of Table 3 we extended the
read length from 50 bp to this 150 bp target. Results
improved but coverage was still underestimated by 13%
and the correlation with paired-end coverage estimates
was 0.934. In the row labeled “kernel estimate”, we used
our method to estimate individual coverage functions for
all 8 mice thereby including high quality multi- and
duplicate reads. Results were now very similar to the
results obtained with the paired-end data with only a
slight overestimation of 0.6 percent. In addition, these
coverage estimates correlated 0.999 with the estimates
from the paired-end data suggesting almost identical
results. We also explored whether using the mean
coverage function produced even more precise results.
This was not the case. The most likely explanation is
the use of a mean function for estimating coverage
when in reality considerable individual differences in
fragment size distributions exist.
Figure 6 shows the coverage standardization factors.
The results indicate that individual variation exists in
coverage standardization factors. Therefore, if coverage
is not corrected, it will differ across samples in proportion to the standardization factors. The issue is that
these differences are not the result of methylation
differences but (arbitrary) differences in fragment size
distributions between samples. Although the bias will be
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Figure 6 Coverage standardization factors. The ○ represent the
standardization factors calculated using the fragment size
distribution obtained from the paired-end data. The Δ represent
coverage standardization factors that would be needed for the read
count method and the + for the extended read count method,
where in both cases we used the fragment size distribution
obtained from the paired-end data for the calculations. The × sign
represent estimates of the standardization factors for which we used
the kernel smoother.

in the opposite direction, Figure 4 shows that this also
occurs for the traditional (extended) read count method.
Thus, regardless of the way coverage is calculated, a
standardization step based on the fragment size
distributions is needed to avoid biased results. The figure
also shows the correspondence between the coverage
standardization factors from the paired-end read data
and coverage calculated after estimating the fragment
size distributions. This suggests that our method can be
used for the purpose of standardizing coverage as well.

Discussion
We developed a non-parametric method that uses
isolated CpGs to estimate sample specific fragment size
distributions from data obtained by sequencing singleend libraries. An important application of the proposed
method is to quantify the amount of methylation by
estimating the number of fragments covering a CpG. To
optimize coverage estimation, we studied several variations.
Although it is possible that the optimal approach varies
somewhat across settings, we found that the two
smoothing methods had very similar overall performance.
Furthermore, the inclusion of particularly high quality
multi-reads, rather than merely using uniquely mapped
reads, improved the precision of the estimated coverage
function. This finding is consistent with other reports
showing that multi-reads contain information and should
not automatically be discarded [33]. Finally, the use of a
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mean coverage function across all samples may result in a
loss of precision. This is because the reduced sampling
fluctuations may not outweigh the biases that are
introduced when a mean function is used to approximate
fragment size distributions that are likely to vary across
samples, even if stringent lab protocols are used to
minimize these differences.
Our data suggested that taking the fragment size
distribution into account may be important to obtain
unbiased coverage estimates even when the standard
(extended) read count method is used for coverage
calculations. Thus, using the mouse sequence data, we
showed that even after careful size selection and the use
of a standardized protocol to fragment DNA, differences
in fragment size distributions can occur that can create
artificial inter-individual differences in coverage estimates.
To avoid these biases we proposed a standardization
factor that can be calculated from the estimated fragment
size distributions.
Further applications of the estimated fragment size
distributions are conceivable as well. For example,
enrichment-based methods are semi-quantitative in the
sense that they do not yield direct estimates of methylation
levels. For the purpose of assessing methylation levels of
sites, methods have been developed to remedy this problem
by normalizing the data based on local CpG density [34,35].
However, the optimal definition of CpG density depends on
the fragment size distribution. For example, the local CpG
density of a site will be higher if the fragments are larger.
Thus, the proposed method can yield a more refined
measure of CpG density.
Our estimator uses data from isolated CpG sites, which
correspond to a modest proportion of all CpGs (e.g. 1.4%
in C57BL/6 mice). It is possible that fragment length distribution differs for the remaining CpG sites. It is important
to note that such a bias would affect our method but
not the coverage function derived from the paired-end
sequencing data that considers all fragments. The fact that
we observed a correlation of .999 between coverage
calculations based on our estimate versus those based on
the paired-end coverage function suggests that a possible
bias does not interfere with the precision of our method. A
somewhat related point is that enrichment protocols may
be less efficient for CpG poor versus CpG rich regions [21],
and that the enrichment will depend on the extent isolated
CpGs are methylated. As the precision of our method
depends on the successful enrichment of fragments with a
single methylated CpG, it may not work as well with
protocols that mainly enrich for CpG dense regions or in
samples where isolated CpGs are not methylated.

Conclusions
Methylation studies are a promising complement to
genetic studies of DNA sequence. However, detailed
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prior biological knowledge is typically lacking, so
methylome-wide association studies will be critical to
detect disease relevant sites. A cost-effective approach
involves sequencing single-end libraries created from
samples that are enriched for methylated DNA
fragments. A limitation of single-end libraries is that the
fragment size distribution is not observed, which
hampers several aspects of the data analysis. In this
article we developed a non-parametric method that uses
isolated CpGs to estimate sample specific fragment size
distributions. We show that our method is highly
accurate and can improve the analysis of cost-effective
MWAS studies that sequence single-end libraries
created from samples that are enriched for methylated
DNA fragments.
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